BerGenBio ASA – Registration of reverse share split
Bergen, Norway, 3 June 2024. Reference is made to the stock exchange announcement made by BerGenBio ASA (the "Company") on 23 May 2024 regarding the Company's annual general meeting resolving a reverse share split of the Company's shares in the ratio 100:1. The reverse share split has today been registered with the Norwegian Register of Business Enterprises. Following such registration, the share capital of the Company is NOK 390,871,160 divided into 39,087,116 shares, each with a nominal value of NOK 10. For further information, please contact: Martin Olin, CEO, BerGenBio ASA